Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive

In brief

This study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population. The breathing intervention, known as Acute Intermittent Hypoxia (AIH), involves breathing brief bouts of low levels of oxygen. Research has found AIH to be a safe and effective intervention resulting in increased ankle strength in people with MS. Here, the study examines arm and hand function before and after AIH. In order to better understand the brain and spinal cord response to AIH, the investigators will measure muscle response, and signals sent from the brain to the arm muscles before and after AIH.

Key facts

Study ID

NCT06390930

Run by

Shirley Ryan AbilityLab

People needed

22

Starts

2025-02-01

Expected to finish

2027-07-01

Last updated by the study team

2026-02-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of relapsing-remitting MS according to the McDonald criteria, over 5 years ago
• Relapse free for at least 6 months
• Expanded Disability Status Scale (EDSS) ≤7
• Index finger abduction strength <5 according to Medical Research Council Scale, or 9-Hole Peg Test score >20 seconds in at least one hand
• Stable disease modifying therapies for at least 6 months
• Individuals taking dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening

You may not qualify if…

• Another diagnosis (e.g., peripheral neuropathies or orthopedic) affecting upper limb function
• Mini-Mental State Examination (MMSE) score <24
• Modified Ashworth Scale score >3 on elbow joint
• Uncontrolled hypertension or hypotension (outside 140/90 and 85/55 mmHg)
• History of epilepsy, chronic obstructive pulmonary disease, or sleep apnea
• Unstable medical conditions, ongoing upper limb therapy, or musculoskeletal pain
• Pregnancy as confirmed by urine test

Where it is running

• Shirley Ryan AbilityLab — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.